表紙:カプセル内視鏡システムの世界市場 - 機会分析・産業予測:コンポーネント、疾患タイプ別(2020年~2030年)
市場調査レポート
商品コード
1097626

カプセル内視鏡システムの世界市場 - 機会分析・産業予測:コンポーネント、疾患タイプ別(2020年~2030年)

Capsule Endoscopy System Market By Component (Capsule Endoscope, Work stations and recorders), By Disease Type (Small Intestine Disorder, Esophageal disorder, Colonic disorder): Global Opportunity Analysis and Industry Forecast, 2020-2030

出版日: | 発行: Allied Market Research | ページ情報: 英文 210 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
カプセル内視鏡システムの世界市場 - 機会分析・産業予測:コンポーネント、疾患タイプ別(2020年~2030年)
出版日: 2022年04月01日
発行: Allied Market Research
ページ情報: 英文 210 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のカプセル内視鏡システム市場は、2020年の6億1,657万米ドルから、2030年には20億米ドルに達し、2021年~2030年の間に12.4%のCAGRで成長すると予測されています。

低侵襲診断治療に対する需要増加、がんの有病率の上昇、高齢者人口の増大、先端技術によるカプセルの導入急増が、カプセル内視鏡システムの世界市場の成長を促進する主要な要因です。しかし、治療や内視鏡機器のコスト高、償還の制限、内視鏡的回収や稀に外科的切除を必要とするカプセル滞留のリスクが、市場成長を抑制しています。一方、主要メーカーの研究開発活動が活発化していることから、予測期間中に多くの革新的で技術的に進んだ製品が商業化されると期待されます。

当レポートでは、世界のカプセル内視鏡システム市場について調査分析し、市場力学、セグメント別・地域別の市場分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

  • 市場の定義と範囲
  • 主要な調査結果
    • 主要な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
  • 市場におけるCOVID-19影響分析

第4章 カプセル内視鏡システム市場:コンポーネント別

  • 概要
    • 市場規模・予測
  • カプセル内視鏡
    • 主要な市場動向・成長要因・機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ワークステーション・レコーダー
    • 主要な市場動向・成長要因・機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第5章 カプセル内視鏡システム市場:疾患タイプ別

  • 概要
    • 市場規模・予測
  • 小腸疾患
    • 主要な市場動向・成長要因・機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 食道疾患
    • 主要な市場動向・成長要因・機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 結腸疾患
    • 主要な市場動向・成長要因・機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 カプセル内視鏡システム市場:地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主要な動向・機会
    • 市場規模・予測:コンポーネント別
    • 市場規模・予測:疾患タイプ別
    • 市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主要な動向・機会
    • 市場規模・予測:コンポーネント別
    • 市場規模・予測:疾患タイプ別
    • 市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋
    • 主要な動向・機会
    • 市場規模・予測:コンポーネント別
    • 市場規模・予測:疾患タイプ別
    • 市場規模・予測:国別
      • 日本
      • 中国
      • インド
      • オーストラリア
      • 韓国
      • その他アジア太平洋
  • LAMEA
    • 主要な動向・機会
    • 市場規模・予測:コンポーネント別
    • 市場規模・予測:疾患タイプ別
    • 市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ
      • その他LAMEA

第7章 企業情勢

  • イントロダクション
  • 主要な成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合ヒートマップ
  • 主要な発展

第8章 企業プロファイル

  • Olympus Corporation
  • CapsoVision Inc.
  • Chongqing Jinshan Science and Technology Group Co.
  • IntroMedic Co.
  • RF Systems Lab
  • Shangxian Minimal Invasive Inc.
  • MEDTRONIC PLC.
  • Fujifilm Holding Corporation
  • Check Cap
  • Anx Robotica
図表

LIST OF TABLES

  • TABLE 1. GLOBAL CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 2. CAPSULE ENDOSCOPY SYSTEM MARKET SIZE, FOR CAPSULE ENDOSCOPE, BY REGION, 2020-2030 ($MILLION)
  • TABLE 3. CAPSULE ENDOSCOPY SYSTEM MARKET FOR CAPSULE ENDOSCOPE, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 4. CAPSULE ENDOSCOPY SYSTEM MARKET SIZE, FOR WORK STATIONS AND RECORDERS, BY REGION, 2020-2030 ($MILLION)
  • TABLE 5. CAPSULE ENDOSCOPY SYSTEM MARKET FOR WORK STATIONS AND RECORDERS, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 6. GLOBAL CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 7. CAPSULE ENDOSCOPY SYSTEM MARKET SIZE, FOR SMALL INTESTINE DISORDER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 8. CAPSULE ENDOSCOPY SYSTEM MARKET FOR SMALL INTESTINE DISORDER, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 9. CAPSULE ENDOSCOPY SYSTEM MARKET SIZE, FOR ESOPHAGEAL DISORDER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 10. CAPSULE ENDOSCOPY SYSTEM MARKET FOR ESOPHAGEAL DISORDER, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 11. CAPSULE ENDOSCOPY SYSTEM MARKET SIZE, FOR COLONIC DISORDER, BY REGION, 2020-2030 ($MILLION)
  • TABLE 12. CAPSULE ENDOSCOPY SYSTEM MARKET FOR COLONIC DISORDER, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 13. CAPSULE ENDOSCOPY SYSTEM MARKET, BY REGION, 2020-2030 ($MILLION)
  • TABLE 14. NORTH AMERICA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 15. NORTH AMERICA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 16. NORTH AMERICA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 17. U.S. CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 18. U.S. CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 19. CANADA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 20. CANADA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 21. MEXICO CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 22. MEXICO CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 23. EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 24. EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 25. EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 26. GERMANY CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 27. GERMANY CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 28. FRANCE CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 29. FRANCE CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 30. U.K. CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 31. U.K. CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 32. ITALY CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 33. ITALY CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 34. SPAIN CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 35. SPAIN CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 36. REST OF EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 37. REST OF EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 38. ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 39. ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 40. ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 41. JAPAN CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 42. JAPAN CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 43. CHINA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 44. CHINA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 45. INDIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 46. INDIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 47. AUSTRALIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 48. AUSTRALIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 49. SOUTH KOREA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 50. SOUTH KOREA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 51. REST OF ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 52. REST OF ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 53. LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 54. LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 55. LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COUNTRY, 2020-2030 ($MILLION)
  • TABLE 56. BRAZIL CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 57. BRAZIL CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 58. SAUDI ARABIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 59. SAUDI ARABIA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 60. SOUTH AFRICA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 61. SOUTH AFRICA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 62. REST OF LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT, 2020-2030 ($MILLION)
  • TABLE 63. REST OF LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE, 2020-2030 ($MILLION)
  • TABLE 64.OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • TABLE 65.OLYMPUS CORPORATION: OPERATING SEGMENTS
  • TABLE 66.OLYMPUS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 67.OLYMPUS CORPORATION: NET SALES,
  • TABLE 68.OLYMPUS CORPORATION: KEY STRATERGIES
  • TABLE 69.CAPSOVISION INC.: COMPANY SNAPSHOT
  • TABLE 70.CAPSOVISION INC.: OPERATING SEGMENTS
  • TABLE 71.CAPSOVISION INC.: PRODUCT PORTFOLIO
  • TABLE 72.CAPSOVISION INC.: NET SALES,
  • TABLE 73.CAPSOVISION INC.: KEY STRATERGIES
  • TABLE 74.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO.: COMPANY SNAPSHOT
  • TABLE 75.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO.: OPERATING SEGMENTS
  • TABLE 76.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO.: PRODUCT PORTFOLIO
  • TABLE 77.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO.: NET SALES,
  • TABLE 78.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO.: KEY STRATERGIES
  • TABLE 79.INTROMEDIC CO.: COMPANY SNAPSHOT
  • TABLE 80.INTROMEDIC CO.: OPERATING SEGMENTS
  • TABLE 81.INTROMEDIC CO.: PRODUCT PORTFOLIO
  • TABLE 82.INTROMEDIC CO.: NET SALES,
  • TABLE 83.INTROMEDIC CO.: KEY STRATERGIES
  • TABLE 84.RF SYSTEMS LAB: COMPANY SNAPSHOT
  • TABLE 85.RF SYSTEMS LAB: OPERATING SEGMENTS
  • TABLE 86.RF SYSTEMS LAB: PRODUCT PORTFOLIO
  • TABLE 87.RF SYSTEMS LAB: NET SALES,
  • TABLE 88.RF SYSTEMS LAB: KEY STRATERGIES
  • TABLE 89.SHANGXIAN MINIMAL INVASIVE INC.: COMPANY SNAPSHOT
  • TABLE 90.SHANGXIAN MINIMAL INVASIVE INC.: OPERATING SEGMENTS
  • TABLE 91.SHANGXIAN MINIMAL INVASIVE INC.: PRODUCT PORTFOLIO
  • TABLE 92.SHANGXIAN MINIMAL INVASIVE INC.: NET SALES,
  • TABLE 93.SHANGXIAN MINIMAL INVASIVE INC.: KEY STRATERGIES
  • TABLE 94.MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 95.MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 96.MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 97.MEDTRONIC PLC.: NET SALES,
  • TABLE 98.MEDTRONIC PLC.: KEY STRATERGIES
  • TABLE 99.FUJIFILM HOLDING CORPORATION: COMPANY SNAPSHOT
  • TABLE 100.FUJIFILM HOLDING CORPORATION: OPERATING SEGMENTS
  • TABLE 101.FUJIFILM HOLDING CORPORATION: PRODUCT PORTFOLIO
  • TABLE 102.FUJIFILM HOLDING CORPORATION: NET SALES,
  • TABLE 103.FUJIFILM HOLDING CORPORATION: KEY STRATERGIES
  • TABLE 104.CHECK CAP: COMPANY SNAPSHOT
  • TABLE 105.CHECK CAP: OPERATING SEGMENTS
  • TABLE 106.CHECK CAP: PRODUCT PORTFOLIO
  • TABLE 107.CHECK CAP: NET SALES,
  • TABLE 108.CHECK CAP: KEY STRATERGIES
  • TABLE 109.ANX ROBOTICA: COMPANY SNAPSHOT
  • TABLE 110.ANX ROBOTICA: OPERATING SEGMENTS
  • TABLE 111.ANX ROBOTICA: PRODUCT PORTFOLIO
  • TABLE 112.ANX ROBOTICA: NET SALES,
  • TABLE 113.ANX ROBOTICA: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CAPSULE ENDOSCOPY SYSTEM MARKET SEGMENTATION
  • FIGURE 2.CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030
  • FIGURE 3.CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CAPSULE ENDOSCOPY SYSTEM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.CAPSULE ENDOSCOPY SYSTEM MARKET,BY COMPONENT,2020(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF CAPSULE ENDOSCOPE CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF WORK STATIONS AND RECORDERS CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030(%)
  • FIGURE 15.CAPSULE ENDOSCOPY SYSTEM MARKET,BY DISEASE TYPE,2020(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF SMALL INTESTINE DISORDER CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF ESOPHAGEAL DISORDER CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF COLONIC DISORDER CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030(%)
  • FIGURE 19.CAPSULE ENDOSCOPY SYSTEM MARKET BY REGION,2020
  • FIGURE 20.U.S. CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 21.CANADA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 22.MEXICO CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 23.GERMANY CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 24.FRANCE CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 25.U.K. CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 26.ITALY CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 27.SPAIN CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 28.REST OF EUROPE CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 29.JAPAN CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 30.CHINA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 31.INDIA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 32.AUSTRALIA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 33.SOUTH KOREA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 34.REST OF ASIA-PACIFIC CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 35.BRAZIL CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 36.SAUDI ARABIA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 37.SOUTH AFRICA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 38.REST OF LAMEA CAPSULE ENDOSCOPY SYSTEM MARKET,2020-2030($MILLION)
  • FIGURE 39. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 40. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 41. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 42.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 43.COMPETITIVE DASHBOARD
  • FIGURE 44.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 45.OLYMPUS CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 46.CAPSOVISION INC..: NET SALES ,($MILLION)
  • FIGURE 47.CHONGQING JINSHAN SCIENCE AND TECHNOLOGY GROUP CO..: NET SALES ,($MILLION)
  • FIGURE 48.INTROMEDIC CO..: NET SALES ,($MILLION)
  • FIGURE 49.RF SYSTEMS LAB.: NET SALES ,($MILLION)
  • FIGURE 50.SHANGXIAN MINIMAL INVASIVE INC..: NET SALES ,($MILLION)
  • FIGURE 51.MEDTRONIC PLC..: NET SALES ,($MILLION)
  • FIGURE 52.FUJIFILM HOLDING CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.CHECK CAP.: NET SALES ,($MILLION)
  • FIGURE 54.ANX ROBOTICA.: NET SALES ,($MILLION)
目次
Product Code: A00574

The global capsule endoscopy system market was valued at $616.57 million in 2020, and is projected to reach $2.0 billion by 2030, growing at a CAGR of 12.4% from 2021 to 2030.

Capsule endoscopes are tiny wireless endoscopic systems that capture images of the body's interior. The endoscopic camera is small enough to fit in a vitamin capsule and can capture hundreds of images, which are subsequently sent to the recorder. Physicians can use capsule endoscopes to acquire images of parts of the body that a regular endoscope cannot reach. It is a technique used for the diagnosis and monitoring of gastrointestinal disorders, including small bowel diseases, colonic diseases, and esophageal diseases using wireless video capsule, data recorder, software, and workstations

Major factors that drive the growth of the global capsule endoscopy systems market include rise demand for minimally invasive diagnostic procedures, increase in prevalence of cancer, growth in geriatric population, and surge in introduction of technologically advanced capsules. However, high cost of treatments and endoscopy equipment, limited reimbursement, and the risk of retention of the capsule may require endoscopic retrieval or rarely surgical resection restrain the market growth. Conversely, many innovative and technologically advanced products gain commercialization during the forecast period, owing to increase in R&D activities of key market players.

The global capsule endoscopy systems market is segmented on the basis of component, disease, and region. According to component, it is divided into capsule endoscopes and recorders &  workstations. Depending on disease, it is divided into small intestine disorder, esophageal disorder, and colonic disorder. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).

The major companies profiled in the report include: Given Imaging (Medtronic), IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd., RF System lab, CapsoVision, Shengxian Minimal Invasive Inc., Check -Cap, Accuread Endoscopy Inc., Fujifilm Holding Corporation, and Anhan Technology (wuhan) co., Ltd.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the capsule endoscopy system market analysis from 2020 to 2030 to identify the prevailing capsule endoscopy system market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the capsule endoscopy system market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global capsule endoscopy system market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Component

  • Capsule Endoscope
  • Work stations and recorders

By Disease Type

  • Small Intestine Disorder
  • Esophageal disorder
  • Colonic disorder

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Olympus Corporation
    • CapsoVision Inc.
    • Chongqing Jinshan Science and Technology Group Co.
    • IntroMedic Co.
    • RF Systems Lab
    • Shangxian Minimal Invasive Inc.
    • MEDTRONIC PLC.
    • Fujifilm Holding Corporation
    • Check Cap
    • Anx Robotica

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CAPSULE ENDOSCOPY SYSTEM MARKET, BY COMPONENT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Capsule Endoscope
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Work stations and recorders
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CAPSULE ENDOSCOPY SYSTEM MARKET, BY DISEASE TYPE

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Small Intestine Disorder
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Esophageal disorder
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Colonic disorder
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CAPSULE ENDOSCOPY SYSTEM MARKET, BY REGION

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 North America
    • 6.2.1 Key trends and opportunities
    • 6.2.2 North America Market size and forecast, by Component
    • 6.2.3 North America Market size and forecast, by Disease Type
    • 6.2.4 North America Market size and forecast, by country
      • 6.2.4.1 U.S.
      • 6.2.4.1.1 Market size and forecast, by Component
      • 6.2.4.1.2 Market size and forecast, by Disease Type
      • 6.2.4.2 Canada
      • 6.2.4.2.1 Market size and forecast, by Component
      • 6.2.4.2.2 Market size and forecast, by Disease Type
      • 6.2.4.3 Mexico
      • 6.2.4.3.1 Market size and forecast, by Component
      • 6.2.4.3.2 Market size and forecast, by Disease Type
  • 6.3 Europe
    • 6.3.1 Key trends and opportunities
    • 6.3.2 Europe Market size and forecast, by Component
    • 6.3.3 Europe Market size and forecast, by Disease Type
    • 6.3.4 Europe Market size and forecast, by country
      • 6.3.4.1 Germany
      • 6.3.4.1.1 Market size and forecast, by Component
      • 6.3.4.1.2 Market size and forecast, by Disease Type
      • 6.3.4.2 France
      • 6.3.4.2.1 Market size and forecast, by Component
      • 6.3.4.2.2 Market size and forecast, by Disease Type
      • 6.3.4.3 U.K.
      • 6.3.4.3.1 Market size and forecast, by Component
      • 6.3.4.3.2 Market size and forecast, by Disease Type
      • 6.3.4.4 Italy
      • 6.3.4.4.1 Market size and forecast, by Component
      • 6.3.4.4.2 Market size and forecast, by Disease Type
      • 6.3.4.5 Spain
      • 6.3.4.5.1 Market size and forecast, by Component
      • 6.3.4.5.2 Market size and forecast, by Disease Type
      • 6.3.4.6 Rest of Europe
      • 6.3.4.6.1 Market size and forecast, by Component
      • 6.3.4.6.2 Market size and forecast, by Disease Type
  • 6.4 Asia-Pacific
    • 6.4.1 Key trends and opportunities
    • 6.4.2 Asia-Pacific Market size and forecast, by Component
    • 6.4.3 Asia-Pacific Market size and forecast, by Disease Type
    • 6.4.4 Asia-Pacific Market size and forecast, by country
      • 6.4.4.1 Japan
      • 6.4.4.1.1 Market size and forecast, by Component
      • 6.4.4.1.2 Market size and forecast, by Disease Type
      • 6.4.4.2 China
      • 6.4.4.2.1 Market size and forecast, by Component
      • 6.4.4.2.2 Market size and forecast, by Disease Type
      • 6.4.4.3 India
      • 6.4.4.3.1 Market size and forecast, by Component
      • 6.4.4.3.2 Market size and forecast, by Disease Type
      • 6.4.4.4 Australia
      • 6.4.4.4.1 Market size and forecast, by Component
      • 6.4.4.4.2 Market size and forecast, by Disease Type
      • 6.4.4.5 South Korea
      • 6.4.4.5.1 Market size and forecast, by Component
      • 6.4.4.5.2 Market size and forecast, by Disease Type
      • 6.4.4.6 Rest of Asia-Pacific
      • 6.4.4.6.1 Market size and forecast, by Component
      • 6.4.4.6.2 Market size and forecast, by Disease Type
  • 6.5 LAMEA
    • 6.5.1 Key trends and opportunities
    • 6.5.2 LAMEA Market size and forecast, by Component
    • 6.5.3 LAMEA Market size and forecast, by Disease Type
    • 6.5.4 LAMEA Market size and forecast, by country
      • 6.5.4.1 Brazil
      • 6.5.4.1.1 Market size and forecast, by Component
      • 6.5.4.1.2 Market size and forecast, by Disease Type
      • 6.5.4.2 Saudi Arabia
      • 6.5.4.2.1 Market size and forecast, by Component
      • 6.5.4.2.2 Market size and forecast, by Disease Type
      • 6.5.4.3 South Africa
      • 6.5.4.3.1 Market size and forecast, by Component
      • 6.5.4.3.2 Market size and forecast, by Disease Type
      • 6.5.4.4 Rest of LAMEA
      • 6.5.4.4.1 Market size and forecast, by Component
      • 6.5.4.4.2 Market size and forecast, by Disease Type

CHAPTER 7: COMPANY LANDSCAPE

  • 7.1. Introduction
  • 7.2. Top winning strategies
  • 7.3. Product Mapping of Top 10 Player
  • 7.4. Competitive Dashboard
  • 7.5. Competitive Heatmap
  • 7.6. Key developments

CHAPTER 8: COMPANY PROFILES

  • 8.1 Olympus Corporation
    • 8.1.1 Company overview
    • 8.1.2 Company snapshot
    • 8.1.3 Operating business segments
    • 8.1.4 Product portfolio
    • 8.1.5 Business performance
    • 8.1.6 Key strategic moves and developments
  • 8.2 CapsoVision Inc.
    • 8.2.1 Company overview
    • 8.2.2 Company snapshot
    • 8.2.3 Operating business segments
    • 8.2.4 Product portfolio
    • 8.2.5 Business performance
    • 8.2.6 Key strategic moves and developments
  • 8.3 Chongqing Jinshan Science and Technology Group Co.
    • 8.3.1 Company overview
    • 8.3.2 Company snapshot
    • 8.3.3 Operating business segments
    • 8.3.4 Product portfolio
    • 8.3.5 Business performance
    • 8.3.6 Key strategic moves and developments
  • 8.4 IntroMedic Co.
    • 8.4.1 Company overview
    • 8.4.2 Company snapshot
    • 8.4.3 Operating business segments
    • 8.4.4 Product portfolio
    • 8.4.5 Business performance
    • 8.4.6 Key strategic moves and developments
  • 8.5 RF Systems Lab
    • 8.5.1 Company overview
    • 8.5.2 Company snapshot
    • 8.5.3 Operating business segments
    • 8.5.4 Product portfolio
    • 8.5.5 Business performance
    • 8.5.6 Key strategic moves and developments
  • 8.6 Shangxian Minimal Invasive Inc.
    • 8.6.1 Company overview
    • 8.6.2 Company snapshot
    • 8.6.3 Operating business segments
    • 8.6.4 Product portfolio
    • 8.6.5 Business performance
    • 8.6.6 Key strategic moves and developments
  • 8.7 MEDTRONIC PLC.
    • 8.7.1 Company overview
    • 8.7.2 Company snapshot
    • 8.7.3 Operating business segments
    • 8.7.4 Product portfolio
    • 8.7.5 Business performance
    • 8.7.6 Key strategic moves and developments
  • 8.8 Fujifilm Holding Corporation
    • 8.8.1 Company overview
    • 8.8.2 Company snapshot
    • 8.8.3 Operating business segments
    • 8.8.4 Product portfolio
    • 8.8.5 Business performance
    • 8.8.6 Key strategic moves and developments
  • 8.9 Check Cap
    • 8.9.1 Company overview
    • 8.9.2 Company snapshot
    • 8.9.3 Operating business segments
    • 8.9.4 Product portfolio
    • 8.9.5 Business performance
    • 8.9.6 Key strategic moves and developments
  • 8.10 Anx Robotica
    • 8.10.1 Company overview
    • 8.10.2 Company snapshot
    • 8.10.3 Operating business segments
    • 8.10.4 Product portfolio
    • 8.10.5 Business performance
    • 8.10.6 Key strategic moves and developments